This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related letter  • Similar articles in JAMA  Social Bookmarking   What's this?

Meir J. Stampfer, MD; Ronald M. Krauss, MD; Jing Ma, MD; Patricia J. Blanche; Laura G. Holl; Frank M. Sacks, MD; Charles H. Hennekens, MD

JAMA. 1996;276(11):882-888.

Abstract
Objective.
—To test whether a predominance of small, dense low-density lipoprotein (LDL) particles and elevated triglyceride levels are independent risk factors for myocardial infarction (MI).

Design.
—Nested case-control study with prospectively collected samples.

Setting.
—Prospective cohort study.

Participants.
—Blood samples were collected at baseline (85% nonfasting samples) from 14916 men aged 40 to 84 years in the Physicians' Health Study.

Main Outcome Measurements.
—Myocardial infarction diagnosed during 7 years of follow-up.

Results.
—Cases (n=266) had a significantly smaller LDL diameter (mean [SD], 25.6 [0.9] nm) than did controls (n=308) matched on age and smoking (mean [SD], 25.9 [8] nm; P<.001). Cases also had higher median triglyceride levels (1.90 vs 1.49 mmol/L [168 vs 132 mg/dL]; P<.001). The LDL diameter had a high inverse correlation with triglyceride level (r=-0.71), and a high direct correlation with high-density lipoprotein cholesterol (HDL-C) level (r=0.60). We observed a significant multiplicative interaction between triglyceride and total cholesterol (TC) levels (P=.01). After simultaneous adjustment for lipids and a variety of coronary risk factors, LDL particle diameter was no longer a statistically significant risk indicator, with a relative risk (RR) of 1.09 (95% confidence interval [CI], 0.85-1.40) per 0.8-nm decrease. However, triglyceride level remained significant with an RR of 1.40 (95% CI, 1.10-1.77) per 1.13 mmol/L (100-mg/dl) increase. The association between triglyceride level and MI risk appeared linear across the distribution; men in the highest quintile had a risk about 2.5 times that of those in the lowest quintile. The TC level, but not HDL-C level, also remained significant, with an RR of 1.80 (95% CI, 1.44-2.26) per 1.03-mmol/L (40-mg/dL) increase.

Conclusions.
—These findings indicate that nonfasting triglyceride levels appear to be a strong and independent predictor of future risk of MI, particularly when the total cholesterol level is also elevated. In contrast, LDL particle diameter is associated with risk of MI, but not after adjustment for triglyceride level. Increased triglyceride level, small LDL particle diameter, and decreased HDL-C levels appear to reflect underlying metabolic perturbations with adverse consequences for risk of MI; elevated triglyceride levels may help identify high-risk individuals.

Author Affiliations
From Channing Laboratory (Drs Stampfer, Ma, and Sacks) and the Division of Preventive Medicine (Dr Hennekens), Departments of Medicine and Ambulatory Care and Prevention (Dr Hennekens), Brigham and Women's Hospital and Harvard Medical School, Boston, Mass; the Departments of Epidemiology (Drs Stampfer and Hennekens) and Nutrition (Drs Stampfer and Sacks), Harvard School of Public Health, Boston; and the Department of Molecular and Nuclear Medicine, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, Calif (Dr Krauss and Mss Blanche and Holl).

Footnotes
Corresponding author: Meir J. Stampfer, MD, Channing Laboratory, 181 Longwood Ave, Boston, MA 02115.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Triglycerides and Small, Dense Low-Density Lipoprotein
Enas A. Enas, Benoît Lamarche, Gilles R. Dagenais, and Jean-Pierre Després
JAMA. 1998;280(23):1990-1991.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

In Vivo Insulin Sensitivity and Lipoprotein Particle Size and Concentration in Black and White Children
Burns et al.
Diabetes Care 2009;32:2087-2093.
ABSTRACT | FULL TEXT  

Ion Mobility Analysis of Lipoprotein Subfractions Identifies Three Independent Axes of Cardiovascular Risk
Musunuru et al.
Arterioscler. Thromb. Vasc. Bio. 2009;29:1975-1980.
ABSTRACT | FULL TEXT  

Measures of postprandial lipoproteins are not associated with coronary artery disease in patients with type 2 diabetes mellitus
Reyes-Soffer et al.
J. Lipid Res. 2009;50:1901-1909.
ABSTRACT | FULL TEXT  

Apolipoprotein B but not LDL Cholesterol Is Associated With Coronary Artery Calcification in Type 2 Diabetic Whites
Martin et al.
Diabetes 2009;58:1887-1892.
ABSTRACT | FULL TEXT  

Advanced Lipoprotein Testing and Subfractionation Are Clinically Useful
Superko
Circulation 2009;119:2383-2395.
FULL TEXT  

Advanced Lipoprotein Testing and Subfractionation Are Not (Yet) Ready for Routine Clinical Use
Mora
Circulation 2009;119:2396-2404.
FULL TEXT  

Systematic Review: Association of Low-Density Lipoprotein Subfractions With Cardiovascular Outcomes
Ip et al.
ANN INTERN MED 2009;150:474-484.
ABSTRACT | FULL TEXT  

Evaluation of Lipid Profiles and the Use of Omega-3 Essential Fatty Acid in Professional Football Players
Yates et al.
Sports Health: A Multidisciplinary Approach 2009;1:21-30.
ABSTRACT | FULL TEXT  

VAP II analysis of lipoprotein subclasses in mixed hyperlipidemic patients on treatment with ezetimibe/simvastatin and fenofibrate
Farnier et al.
J. Lipid Res. 2008;49:2641-2647.
ABSTRACT | FULL TEXT  

Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events
Mora et al.
Circulation 2008;118:993-1001.
ABSTRACT | FULL TEXT  

The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study
Svensson et al.
Nephrol Dial Transplant 2008;23:2918-2924.
ABSTRACT | FULL TEXT  

The Role of Statin Drugs in the Management of the Peripheral Vascular Patient
Samson
VASC ENDOVASCULAR SURG 2008;42:352-366.
ABSTRACT  

Relationship of Abdominal Visceral and Subcutaneous Adipose Tissue With Lipoprotein Particle Number and Size in Type 2 Diabetes
Sam et al.
Diabetes 2008;57:2022-2027.
ABSTRACT | FULL TEXT  

The lipoprotein subfraction profile: heritability and identification of quantitative trait loci
Kaess et al.
J. Lipid Res. 2008;49:715-723.
ABSTRACT | FULL TEXT  

Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes
Lund et al.
Eur J Endocrinol 2008;158:35-46.
ABSTRACT | FULL TEXT  

Fasting versus Nonfasting Triglycerides and the Prediction of Cardiovascular Risk: Do We Need to Revisit the Oral Triglyceride Tolerance Test?
Ridker
Clin. Chem. 2008;54:11-13.
FULL TEXT  

Nonfasting Triglycerides and Cardiovascular Risk Reply
Nordestgaard et al.
JAMA 2007;298:2005-2005.
FULL TEXT  

Cholesterol levels in small LDL particles predict the risk of coronary heart disease in the EPIC-Norfolk prospective population study
Arsenault et al.
Eur Heart J 2007;28:2770-2777.
ABSTRACT | FULL TEXT  

Changes in Triglyceride Levels and Risk for Coronary Heart Disease in Young Men
Tirosh et al.
ANN INTERN MED 2007;147:377-385.
ABSTRACT | FULL TEXT  

Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
Nordestgaard et al.
JAMA 2007;298:299-308.
ABSTRACT | FULL TEXT  

Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in Women
Bansal et al.
JAMA 2007;298:309-316.
ABSTRACT | FULL TEXT  

Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies
Sarwar et al.
Circulation 2007;115:450-458.
ABSTRACT | FULL TEXT  

Thematic review series: Patient-Oriented Research. Dietary fat, carbohydrate, and protein: effects on plasma lipoprotein patterns
Lichtenstein
J. Lipid Res. 2006;47:1661-1667.
ABSTRACT | FULL TEXT  

Diet in the management of weight loss
Strychar
CMAJ 2006;174:56-63.
ABSTRACT | FULL TEXT  

Low-density lipoprotein size and cardiovascular risk assessment
Rizzo and Berneis
QJM 2006;99:1-14.
ABSTRACT | FULL TEXT  

A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia: Response to Goldberg et al.
Bell
Diabetes Care 2005;28:2983-2984.
FULL TEXT  

Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B in the Prediction of Coronary Heart Disease in Men
Pischon et al.
Circulation 2005;112:3375-3383.
ABSTRACT | FULL TEXT  

Dietary and Genetic Probes of Atherogenic Dyslipidemia
Krauss
Arterioscler. Thromb. Vasc. Bio. 2005;25:2265-2272.
ABSTRACT | FULL TEXT  

Drinking Frequency, Mediating Biomarkers, and Risk of Myocardial Infarction in Women and Men
Mukamal et al.
Circulation 2005;112:1406-1413.
ABSTRACT | FULL TEXT  

Quantification of Lipoprotein Subclasses by Proton Nuclear Magnetic Resonance-Based Partial Least-Squares Regression Models
Petersen et al.
Clin. Chem. 2005;51:1457-1461.
ABSTRACT | FULL TEXT  

Advanced Lipoprotein Testing Does Not Improve Identification of Subclinical Atherosclerosis in Young Adults: The Bogalusa Heart Study
Tzou et al.
ANN INTERN MED 2005;142:742-750.
ABSTRACT | FULL TEXT  

Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease
Hopkins et al.
J Am Coll Cardiol 2005;45:1003-1012.
ABSTRACT | FULL TEXT  

Rosiglitazone Improves Postprandial Triglyceride and Free Fatty Acid Metabolism in Type 2 Diabetes
van Wijk et al.
Diabetes Care 2005;28:844-849.
ABSTRACT | FULL TEXT  

Hormone Therapy, Lipoprotein Subclasses, and Coronary Calcification: The Healthy Women Study
Mackey et al.
Arch Intern Med 2005;165:510-515.
ABSTRACT | FULL TEXT  

Biochemical risk markers: a novel area for better prediction of renal risk?
Stuveling et al.
Nephrol Dial Transplant 2005;20:497-508.
FULL TEXT  

Increased ApoB in Small Dense LDL Particles Predicts Premature Coronary Artery Disease
Brunzell
Arterioscler. Thromb. Vasc. Bio. 2005;25:474-475.
FULL TEXT  

Low-Density Lipoprotein Subfractions and the Long-Term Risk of Ischemic Heart Disease in Men: 13-Year Follow-Up Data From the Quebec Cardiovascular Study
St-Pierre et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:553-559.
ABSTRACT | FULL TEXT  

Conditional Risk Factors for Atherosclerosis
Kullo and Ballantyne
Mayo Clin Proc. 2005;80:219-230.
ABSTRACT  

Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes
Tushuizen et al.
Postgrad. Med. J. 2005;81:1-6.
ABSTRACT | FULL TEXT  

Low-Density Lipoprotein Triglycerides Associated With Low-Grade Systemic Inflammation, Adhesion Molecules, and Angiographic Coronary Artery Disease: The Ludwigshafen Risk and Cardiovascular Health Study
Marz et al.
Circulation 2004;110:3068-3074.
ABSTRACT | FULL TEXT  

Serum Triglycerides as a Risk Factor for Cardiovascular Diseases in the Asia-Pacific Region
Asia Pacific Cohort Studies Collaboration
Circulation 2004;110:2678-2686.
ABSTRACT | FULL TEXT  

Low-Density Lipoprotein Particle Size Loci in Familial Combined Hyperlipidemia: Evidence for Multiple Loci From a Genome Scan
Badzioch et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:1942-1950.
ABSTRACT | FULL TEXT  

Understanding lipoproteins as transporters of cholesterol and other lipids
Biggerstaff and Wooten
Adv. Physiol. Educ. 2004;28:105-106.
ABSTRACT | FULL TEXT  

Milk-Derived Fatty Acids Are Associated with a More Favorable LDL Particle Size Distribution in Healthy Men
Sjogren et al.
J. Nutr. 2004;134:1729-1735.
ABSTRACT | FULL TEXT  

Sex and Age Differences in Lipoprotein Subclasses Measured by Nuclear Magnetic Resonance Spectroscopy: The Framingham Study
Freedman et al.
Clin. Chem. 2004;50:1189-1200.
ABSTRACT | FULL TEXT  

Prospective Study of Plasma Carotenoids and Tocopherols in Relation to Risk of Ischemic Stroke
Hak et al.
Stroke 2004;35:1584-1588.
ABSTRACT | FULL TEXT  

Atherogenic Lipoprotein Particles in Atherosclerosis
Carmena et al.
Circulation 2004;109:III-2-III-7.
ABSTRACT | FULL TEXT  

Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome: Importance of Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Disease Risk
Carr and Brunzell
J. Clin. Endocrinol. Metab. 2004;89:2601-2607.
ABSTRACT | FULL TEXT  

Study of agreement between LDL size as measured by nuclear magnetic resonance and gradient gel electrophoresis
Witte et al.
J. Lipid Res. 2004;45:1069-1076.
ABSTRACT | FULL TEXT  

Relationship between cholesteryl ester transfer protein and LDL heterogeneity in familial hypercholesterolemia
Hogue et al.
J. Lipid Res. 2004;45:1077-1083.
ABSTRACT | FULL TEXT  

Genetics of LDL particle heterogeneity: from genetic epidemiology to DNA-based variations
Bosse et al.
J. Lipid Res. 2004;45:1008-1026.
ABSTRACT | FULL TEXT  

Combined data from LDL composition and size measurement are compatible with a discoid particle shape
Teerlink et al.
J. Lipid Res. 2004;45:954-966.
ABSTRACT | FULL TEXT  

Implications of plasma concentrations of adiponectin in patients with coronary artery disease
Nakamura et al.
Heart 2004;90:528-533.
ABSTRACT | FULL TEXT  

A Solid Dietary Fat Containing Fish Oil Redistributes Lipoprotein Subclasses without Increasing Oxidative Stress in Men
Tholstrup et al.
J. Nutr. 2004;134:1051-1057.
ABSTRACT | FULL TEXT  

New Perspectives on the Use of Niacin in the Treatment of Lipid Disorders
McKenney
Arch Intern Med 2004;164:697-705.
ABSTRACT | FULL TEXT  

Clinical Significance of Small Dense Low-Density Lipoprotein Cholesterol Levels Determined by the Simple Precipitation Method
Hirano et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:558-563.
ABSTRACT | FULL TEXT  

Dietary linolenic acid is inversely associated with plasma triacylglycerol: the National Heart, Lung, and Blood Institute Family Heart Study
Djousse et al.
Am. J. Clin. Nutr. 2003;78:1098-1102.
ABSTRACT | FULL TEXT  

Cholesterol and the Risk of Ischemic Stroke
Bowman et al.
Stroke 2003;34:2930-2934.
ABSTRACT | FULL TEXT  

Genome-wide scan for quantitative trait loci influencing LDL size and plasma triglyceride in familial hypertriglyceridemia
Austin et al.
J. Lipid Res. 2003;44:2161-2168.
ABSTRACT | FULL TEXT  

Low-Density Lipoprotein Size and Cardiovascular Disease: A Reappraisal
Sacks and Campos
J. Clin. Endocrinol. Metab. 2003;88:4525-4532.
FULL TEXT  

High Carbohydrate and High Monounsaturated Fatty Acid Diets Similarly Affect LDL Electrophoretic Characteristics in Men Who Are Losing Weight
Archer et al.
J. Nutr. 2003;133:3124-3129.
ABSTRACT | FULL TEXT  

Pioglitazone Reduces Atherogenic Dense LDL Particles in Nondiabetic Patients With Arterial Hypertension: A double-blind, placebo-controlled study
Winkler et al.
Diabetes Care 2003;26:2588-2594.
ABSTRACT | FULL TEXT  

Plasma Carotenoids and Tocopherols and Risk of Myocardial Infarction in a Low-Risk Population of US Male Physicians
Hak et al.
Circulation 2003;108:802-807.
ABSTRACT | FULL TEXT  

The Human Apolipoprotein AV Gene Is Regulated by Peroxisome Proliferator-activated Receptor-{alpha} and Contains a Novel Farnesoid X-activated Receptor Response Element
Prieur et al.
J. Biol. Chem. 2003;278:25468-25480.
ABSTRACT | FULL TEXT  

Carbohydrates, dietary glycaemic load and glycaemic index, and risk of acute myocardial infarction
Tavani et al.
Heart 2003;89:722-726.
ABSTRACT | FULL TEXT  

Medical Management of Hyperlipidemia/Dyslipidemia
Kreisberg and Oberman
J. Clin. Endocrinol. Metab. 2003;88:2445-2461.
FULL TEXT  

Testosterone administration to men increases hepatic lipase activity and decreases HDL and LDL size in 3 wk
Herbst et al.
Am. J. Physiol. Endocrinol. Metab. 2003;284:E1112-E1118.
ABSTRACT | FULL TEXT  

Relation of Triglyceride Levels, Fasting and Nonfasting, to Fatal and Nonfatal Coronary Heart Disease
Eberly et al.
Arch Intern Med 2003;163:1077-1083.
ABSTRACT | FULL TEXT  

Relationships Between Low-Density Lipoprotein Particle Size, Plasma Lipoproteins, and Progression of Coronary Artery Disease: The Diabetes Atherosclerosis Intervention Study (DAIS)
Vakkilainen et al.
Circulation 2003;107:1733-1737.
ABSTRACT | FULL TEXT  

Smallest LDL Particles Are Most Strongly Related to Coronary Disease Progression in Men
Williams et al.
Arterioscler. Thromb. Vasc. Bio. 2003;23:314-321.
ABSTRACT | FULL TEXT  

Carbohydrate Intake Is Associated with Diet Quality and Risk Factors for Cardiovascular Disease in U.S. Adults: NHANES III
Yang et al.
J. Am. Coll. Nutr. 2003;22:71-79.
ABSTRACT | FULL TEXT  

Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets
Schwarz et al.
Am. J. Clin. Nutr. 2003;77:43-50.
ABSTRACT | FULL TEXT  

Hormone Replacement Therapy and Risk of Cardiovascular Disease: Implications of the Results of the Women's Health Initiative
Kuller
Arterioscler. Thromb. Vasc. Bio. 2003;23:11-16.
ABSTRACT | FULL TEXT  

Effect of Fluvastatin Slow-Release on Low Density Lipoprotein (LDL) Subfractions in Patients with Type 2 Diabetes Mellitus: Baseline LDL Profile Determines Specific Mode of Action
Winkler et al.
J. Clin. Endocrinol. Metab. 2002;87:5485-5490.
ABSTRACT | FULL TEXT  

Oral Fat Exposure Increases the First Phase Triacylglycerol Concentration Due to Release of Stored Lipid in Humans
Mattes
J. Nutr. 2002;132:3656-3662.
ABSTRACT | FULL TEXT  

Common problems in the management of hypertriglyceridemia
Fung and Frohlich
CMAJ 2002;167:1261-1266.
FULL TEXT  

Coronary atherogenic risk factors in women
Stangl et al.
Eur Heart J 2002;23:1738-1752.
FULL TEXT  

Nonfasting Apolipoprotein B and Triglyceride Levels as a Useful Predictor of Coronary Heart Disease Risk in Middle-Aged UK Men
Talmud et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:1918-1923.
ABSTRACT | FULL TEXT  

Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in Women
Blake et al.
Circulation 2002;106:1930-1937.
ABSTRACT | FULL TEXT  

Effect of Fish Oil Versus Corn Oil Supplementation on LDL and HDL Subclasses in Type 2 Diabetic Patients
Petersen et al.
Diabetes Care 2002;25:1704-1708.
ABSTRACT | FULL TEXT  

Metabolic origins and clinical significance of LDL heterogeneity
Berneis and Krauss
J. Lipid Res. 2002;43:1363-1379.
ABSTRACT | FULL TEXT  

High-fiber oat cereal compared with wheat cereal consumption favorably alters LDL-cholesterol subclass and particle numbers in middle-aged and older men
Davy et al.
Am. J. Clin. Nutr. 2002;76:351-358.
ABSTRACT | FULL TEXT  

Selective and independent associations of phospholipid transfer protein and hepatic lipase with the LDL subfraction distribution
Murdoch et al.
J. Lipid Res. 2002;43:1256-1263.
ABSTRACT | FULL TEXT  

Orphan Nuclear Hormone Receptor Rev-erbalpha Regulates the Human Apolipoprotein CIII Promoter
Coste and Rodriguez
J. Biol. Chem. 2002;277:27120-27129.
ABSTRACT | FULL TEXT  

A single daily dose of soybean phytosterols in ground beef decreases serum total cholesterol and LDL cholesterol in young, mildly hypercholesterolemic men
Matvienko et al.
Am. J. Clin. Nutr. 2002;76:57-64.
ABSTRACT | FULL TEXT  

Cholesteryl Ester Transfer Protein TaqI B2B2 Genotype Is Associated With Higher HDL Cholesterol Levels and Lower Risk of Coronary Heart Disease End Points in Men With HDL Deficiency: Veterans Affairs HDL Cholesterol Intervention Trial
Brousseau et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:1148-1154.
ABSTRACT | FULL TEXT  

Nuclear Magnetic Resonance Spectroscopy of Lipoproteins and Risk of Coronary Heart Disease in the Cardiovascular Health Study
Kuller et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:1175-1180.
ABSTRACT | FULL TEXT  

Characterization of LDL Particle Size Among Carriers of a Defective or a Null Mutation in the Lipoprotein Lipase Gene: The Quebec LIPD Study
Ruel et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:1181-1186.
ABSTRACT | FULL TEXT  

The Scientific Evidence for a Beneficial Health Relationship Between Walnuts and Coronary Heart Disease
Feldman
J. Nutr. 2002;132:1062S-1101.
ABSTRACT | FULL TEXT  

LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins
Vakkilainen et al.
J. Lipid Res. 2002;43:598-603.
ABSTRACT | FULL TEXT  

Dietary Mono- and Polyunsaturated Fatty Acids Similarly Affect LDL Size in Healthy Men and Women
Kratz et al.
J. Nutr. 2002;132:715-718.
ABSTRACT | FULL TEXT  

Contribution of Hepatic Lipase, Lipoprotein Lipase, and Cholesteryl Ester Transfer Protein to LDL and HDL Heterogeneity in Healthy Women
Carr et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:667-673.
ABSTRACT | FULL TEXT  

Pioglitazone reduces atherogenic dense low density lipoprotein (LDL) particles in patients with type 2 diabetes mellitus
Winkler et al.
British Journal of Diabetes & Vascular Disease 2002;2:143-148.
ABSTRACT  

Abnormal low-density lipoprotein subfraction profile in patients with untreated hypertension
Landray et al.
QJM 2002;95:165-171.
ABSTRACT | FULL TEXT  

Can Measurement of Serum Apolipoprotein B Replace the Lipid Profile Monitoring of Patients with Lipoprotein Disorders?
Miremadi et al.
Clin. Chem. 2002;48:484-488.
ABSTRACT | FULL TEXT  

Is the Size of Low-Density Lipoprotein Particles Related to the Risk of Coronary Heart Disease?
Krauss et al.
JAMA 2002;287:712-713.
FULL TEXT  

A rapid single-step centrifugation method for determination of HDL, LDL, and VLDL cholesterol, and TG, and identification of predominant LDL subclass
Sawle et al.
J. Lipid Res. 2002;43:335-343.
ABSTRACT | FULL TEXT